[4] [6] The SmPC for tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, similarly documents modest mean heart rate increases
Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
Screenings or non-specific abnormal lab findings
The lid should be tight and puncture-resistant
The portal and intake forms look bare-bones, almost like a Google Form, which did not inspire confidence in the platforms security posture
While heart attacks are not a standard risk for healthy people taking oral supplements, there are some minor side effects to be aware of